| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/01/2004 | EP1451578A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 09/01/2004 | EP1451572A2 Multi-disciplinary approach to validating or identifying targets using an in vivo system |
| 09/01/2004 | EP1451571A2 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same |
| 09/01/2004 | EP1451369A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201 |
| 09/01/2004 | EP1451364A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 09/01/2004 | EP1451329A2 Genetic vaccine against human immunodeficiency virus |
| 09/01/2004 | EP1451324A2 G-protein coupled receptor lustr2 and uses thereof |
| 09/01/2004 | EP1451316A2 Method for producing transgenic birds and fish |
| 09/01/2004 | EP1451307A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/01/2004 | EP1451300A2 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
| 09/01/2004 | EP1451296A2 Expression of polypeptides in rod outer segment membranes |
| 09/01/2004 | EP1451222A2 Novel proteins with il-6 inhibiting activity |
| 09/01/2004 | EP1450862A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 09/01/2004 | EP1450861A2 Targeting nucleic acids to a cellular nucleus |
| 09/01/2004 | EP1450831A2 Methods of treatment in situ in the lungs of mammals |
| 09/01/2004 | EP1450828A2 In situ immunization |
| 09/01/2004 | EP1450821A1 Immunostimulatory oligodeoxynucleotides |
| 09/01/2004 | EP1450778A2 Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases |
| 09/01/2004 | EP1450751A2 Nanoparticle delivery vehicle |
| 09/01/2004 | EP1450611A2 Method for the generation of antigen-specific lymphocytes |
| 09/01/2004 | EP1450605A2 A composition and method to alter lean body mass and bone properties in a subject |
| 09/01/2004 | EP1237541B1 Liposomes comprising a complex of a polyanionic compound and calcium phosphate |
| 09/01/2004 | EP1165135B1 Methods of screening for compounds modulating fxr receptors |
| 09/01/2004 | EP1089764B1 Stimulating the immune system |
| 09/01/2004 | EP0975764B1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 09/01/2004 | EP0808630B1 Cancer control |
| 09/01/2004 | CN1526072A Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 09/01/2004 | CN1526025A Genes expressed in breast cancer as prognostic and therapeutic targets |
| 09/01/2004 | CN1526018A Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/01/2004 | CN1526016A Method for stabilization of nucleic acids |
| 09/01/2004 | CN1526014A Paramyxovirus vectors for introducing foreign genes into skeletal muscle |
| 09/01/2004 | CN1526012A A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 09/01/2004 | CN1526011A Inhibition of apoptosis process and improvement of cell performance |
| 09/01/2004 | CN1525980A Tumor antigen peptides originating in cyclophilin B |
| 09/01/2004 | CN1525864A Mucin peptide with immunoenhancing properties |
| 09/01/2004 | CN1524575A Virulence genes and proteins, and their use |
| 09/01/2004 | CN1164756C Nucleic acid transporter containing polypeptide and recombinant virus vector |
| 09/01/2004 | CN1164754C DNA vaccine carrier |
| 08/31/2004 | US6784291 Splice-region antisense composition and method |
| 08/31/2004 | US6784164 Choline binding proteins for anti-pneumococcal vaccines |
| 08/31/2004 | US6784162 Replacement lipoprotein lipase gene is expressed in the individual to produce a functional lipoprotein lipase enzyme |
| 08/31/2004 | US6784153 Identify molecules that can bind to organ or tissue specific markers and, therefore, can home to the organ or tissue; membrane dipeptidase (mdp)-binding homing molecule, which is a molecule that selectively homes to lung endothelium |
| 08/31/2004 | US6783981 Capable of delivering anti-viral inhibitory rna molecules to target cells; gene therapy |
| 08/31/2004 | US6783980 Nucleotide sequences for use in the generation of gene transfer tools |
| 08/31/2004 | US6783979 Mink-related peptide 1 (mirp1), hyperpolarization-activated cyclic nucleotide (hcn); for assaying drug effects on heart rate |
| 08/31/2004 | US6783977 Internal ribosome entry site and vector containing same |
| 08/31/2004 | US6783971 Isolated nucleic acid molecules comprising polynucleotides encoding a glycosylation enzyme |
| 08/31/2004 | US6783956 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 08/31/2004 | US6783954 VEGF nucleic acid and amino acid sequences |
| 08/31/2004 | US6783952 Deleting portion of eukaryotic nucleotide sequence encoding cerebral cortical voltage-dependent calcium channel alpha 2 subunit yielding soluble secreted protein retaining affinity for (3h)gabapentin |
| 08/31/2004 | US6783935 Genetic polymorphism of MxA protein and use thereof |
| 08/31/2004 | US6783931 Amine-derivatized nucleosides and oligonucleosides |
| 08/31/2004 | US6783762 Product and method for obtaining specific immunization with one or more antigens |
| 08/31/2004 | US6783758 Diagnosis and treatment of malignant neoplasms |
| 08/31/2004 | US6783756 Methods for regulating gene expression |
| 08/26/2004 | WO2004072305A2 Atlastin |
| 08/26/2004 | WO2004072293A2 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor |
| 08/26/2004 | WO2004072289A1 Novel virus vector |
| 08/26/2004 | WO2004072269A2 Bex4 nucleic acids, polypeptides, and method of using |
| 08/26/2004 | WO2004072266A2 Antibody affinity engineering by serial epitope-guided complementarity replacement |
| 08/26/2004 | WO2004072253A2 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 08/26/2004 | WO2004072249A2 Polyvinylethers for delivery of polynucleotides to mammalian cells |
| 08/26/2004 | WO2004072248A2 A process for delivering sirna to cardiac muscle tissue |
| 08/26/2004 | WO2004072100A2 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | WO2004071538A2 Topical delivery of cosmetic agents |
| 08/26/2004 | WO2004071534A1 Preventives/remedies for kidney diseases |
| 08/26/2004 | WO2004071468A2 Short immunomodulatory oligonucleotides |
| 08/26/2004 | WO2004071461A2 Tra16 a tr4/tr2 repressor |
| 08/26/2004 | WO2004071458A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 08/26/2004 | WO2004071441A2 Compositions and methods to modulate immune and inflammatory responses |
| 08/26/2004 | WO2004071430A2 RNAi TARGETING OF VIRUSES |
| 08/26/2004 | WO2004071429A2 Lung inflammation treatment |
| 08/26/2004 | WO2004071418A2 Compounds for the treatment of systemic lupus erythematosus |
| 08/26/2004 | WO2004071414A2 Therapeutic anti-hcv (al9) compounds |
| 08/26/2004 | WO2004071407A2 Antisense modulation of ptp1b expression |
| 08/26/2004 | WO2004071405A2 Lactate dehydrogenase: a target and reagent for diabetes therapy |
| 08/26/2004 | WO2004071378A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 08/26/2004 | WO2004044163A9 Methods for identifying risk of melanoma and treatments thereof |
| 08/26/2004 | WO2004044141A8 Conjugated oligomeric compounds and their use in gene modulation |
| 08/26/2004 | WO2004035787A3 Transplantable cell with immune modulator |
| 08/26/2004 | WO2004018684A3 T-cell epitopes in staphylococcal enterotoxin b |
| 08/26/2004 | WO2004013310A3 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 08/26/2004 | WO2004009018A3 Antisense modulation of ptprm expression |
| 08/26/2004 | WO2004006831A3 Method and device for inducing biological processes by micro-organs |
| 08/26/2004 | WO2003092602A3 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/26/2004 | WO2003087320A3 Antagonists of il-21 and modulation of il-21-mediated t cell responses |
| 08/26/2004 | WO2003077859A3 Method of inducing an enhanced immune response against hiv |
| 08/26/2004 | WO2003070911A3 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/26/2004 | WO2002044334A3 Recombinant rsv virus expression systems and vaccines |
| 08/26/2004 | US20040167091 Methods for treating ocular neovascular diseases |
| 08/26/2004 | US20040167089 Immunostimulatory nucleic acid molecules |
| 08/26/2004 | US20040167088 Method of using adenoviral vectors with increased persistence in vivo |
| 08/26/2004 | US20040167087 Complexing of rna with hydrophilic polymer; stabilization |
| 08/26/2004 | US20040167066 Cleavage and polyadenylation complex of precursor mrna |
| 08/26/2004 | US20040167065 human transferases and polynucleotides which identify and encode them; expression vectors, host cells, antibodies, agonists, and antagonists; diagnosing, treating, or preventing disorders associated with aberrant expression of the transferases |
| 08/26/2004 | US20040166573 replicon RNAs are electroporated into permissive cells and are harvested from the surfaces of the cells using a salt wash in which the salt concentration is from about 0.2 to about 5 M sodium/calcium/magnesium/potassium chloride |
| 08/26/2004 | US20040166559 Vectors for gene therapy |
| 08/26/2004 | US20040166553 Caged sensors, regulators and compounds and uses thereof |
| 08/26/2004 | US20040166543 Regulation of cell growth by MUC1 |
| 08/26/2004 | US20040166150 Mixture of expression vector for antihemophilic factor and lipid |